Inhibition of DHCR24/seladin-I impairs cellular homeostasis in prostate cancer

Prostate

Volumn 70, Issue 9, 2010, Pages 921-933

  Battista, Marie Claude ^a   Guimond, Marie Odile ^a   Roberge, Claude ^a   Doueik, Alexandre A ^a   Fazli, Ladan ^b   Gleave, Martin ^b   Sabbagh, Robert ^a   Gallo Payet, Nicole ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Cancer; DU145; Human prostate; LnCaP; Proliferation; Seladin 1

Indexed keywords

3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE; BRAIN PROTEIN; PROTEIN SELADIN 1; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CELL CULTURE; CELL STRAIN LNCAP; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANALYSIS OF VARIANCE; ANDROSTENES; BLOTTING, WESTERN; CELL COUNT; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEOSTASIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NERVE TISSUE PROTEINS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PROSTATE; PROSTATIC NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 77952947178     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21126     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin 2006;56(2):106-130.
2. Shao YH, Demissie K, Shih W, Mehta AR, Stein MN, Roberts CB, Dipaola RS, Lu-Yao GL. Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst 2009;101(18):1280-1283.
3. Ananthanarayanan V, Deaton RJ, Yang XJ, Pins MR, Gann PH. Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer. BMC Cancer 2006;6:73-82.
4. Goswami A, Ranganathan P, Rangnekar VM. The phosphoinositide 3-kinase/Akt1/Par-4 axis: A cancer-selective therapeutic target. Cancer Res 2006;66(6):2889-2892.
5. Isaacs JT, Isaacs WB. Androgen receptor outwits prostate cancer drugs. Nat Med 2004;10(1):26-27. (Pubitemid 38524693)
6. Hager MH, Solomon KR, Freeman MR. The role of cholesterol in prostate cancer. Curr Opin Clin Nutr Metab Care 2006;9(4):379-385.
7. Li YC, Park MJ, Ye SK, Kim CW, Kim YN. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Pathol 2006;168(4):1107-1118, quiz 1404-11105
8. Waterham HR, Koster J, Romeijn GJ, Hennekam RC, Vreken P, Andersson HC, FitzPatrick DR, Kelley RI, Wanders RJ. Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 2001;69(4):685-694.
9. Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G. Evolution of the androgen receptor pathway during progression of prostate cancer. Cancer Res 2006;66(10):5012-5020. (Pubitemid 43844921)
10. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez- Isla T, Behl C, Levkau B, Nitsch RM. The human DIMINUTO/ DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci 2000;20(19):7345-7352.
11. Feng B, Zhang D, Kuriakose G, Devlin CM, Kockx M, Tabas I. Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proc Natl Acad Sci USA 2003;100(18):10423-10428.
12. Mirza R, Hayasaka S, Takagishi Y, Kambe F, Ohmori S, Maki K, Yamamoto M, Murakami K, Kaji T, Zadworny D, Murata Y, Seo H. DHCR24 gene knockout mice demonstrate lethal dermopathy with differentiation and maturation defects in the epidermis. J Invest Dermatol 2006;126(3):638-647.
13. Wu C, Miloslavskaya I, Demontis S, Maestro R, Galaktionov K. Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature 2004;432(7017):640-645. (Pubitemid 39626272)
14. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111(1):58-64.
15. Wright JL, Ellis WJ. Improved prostate cancer detection with anterior apical prostate biopsies. Urol Oncol 2006;24(6):492-495.
16. Battista MC, Roberge C, Otis M, Gallo-Payet N. Seladin-1 expression in rat adrenal gland: Effect of adrenocorticotropic hormone treatment. J Endocrinol 2007;192(1):53-66. (Pubitemid 46444395)
17. Battista MC, Roberge C, Martinez A, Gallo-Payet N. DHCR24/ Seladin-1: A key protein differentially involved in ACTH effects observed in human and rat adrenal cortex. Endocrinology 2009;150:4180-4190.
18. Scholzen T, Gerdes J. The Ki-67 protein: From the known and the unknown. J Cell Physiol 2000;182(3):311-322.
19. Krill D, Shuman M, Thompson MT, Becich MJ, Strom SC. A simple method for the isolation and culture of epithelial and stromal cells from benign and neoplastic prostates. Urology 1997;49(6):981-988. (Pubitemid 27246978)
20. Fliesler SJ, Richards MJ, Miller CY, Cenedella RJ. Cholesterol synthesis in the vertebrate retina: Effects of U18666A on rat retinal structure, photoreceptor membrane assembly, and sterol metabolism and composition. Lipids 2000;35(3):289-296.
21. Volpe JJ, Obert KA. Interrelationships of ubiquinone and sterol syntheses in cultured cells of neural origin. J Neurochem 1982; 38(4):931-938.
22. Krill D, Thomas A, Wu SP, Dhir R, Becich MJ. E-cadherin expression and PSA secretion in human prostate epithelial cells. Urol Res 2001;29(4):287-292. (Pubitemid 32822063)
23. Brusselmans K, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. Int J Cancer 2003;106(6):856-862. (Pubitemid 37071663)
24. Jansen M, Pietiainen VM, Polonen H, Rasilainen L, Koivusalo M, Ruotsalainen U, Jokitalo E, Ikonen E. Cholesterol substitution increases the structural heterogeneity of caveolae. J Biol Chem 2008;283(21):14610-14618.
25. Luciani P, Ferruzzi P, Arnaldi G, Crescioli C, Benvenuti S, Nesi G, Valeri A, Greeve I, Serio M, Mannelli M, Peri A. Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. J Clin Endocrinol Metab 2004;89(3):1332-1339.
26. Fuller PJ, Alexiadis M, Jobling T, McNeilage J. Seladin-1/ DHCR24 expression in normal ovary, ovarian epithelial and granulosa tumours. Clin Endocrinol (Oxf) 2005;63(1):111-115.
27. Bonaccorsi L, Luciani P, Nesi G, Mannucci E, Deledda C, Dichiara F, Paglierani M, Rosati F, Masieri L, Serni S, Carini M, Proietti-Pannunzi L, Monti S, Forti G, Danza G, Serio M, Peri A. Androgen receptor regulation of the seladin-1/DHCR24 gene: Altered expression in prostate cancer. Lab Invest 2008;88(10): 1049-1056.
28. Luciani P, Gelmini S, Ferrante E, Lania A, Benvenuti S, Baglioni S, Mantovani G, Cellai I, Ammannati F, Spada A, Serio M, Peri A. Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 2005;90(11):6156-6161.
29. Nuti F, Luciani P, Marinari E, Erdei E, Bak M, Deledda C, Rosati F, Mazzinghi B, Danza G, Stoop H, Looijenga LH, Peri A, Serio M, Krausz C. Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness. J Pathol 2009;219:491-500.
30. Benaim EA, Pace CM, Roehrborn CG. Gleason score predicts androgen independent progression after androgen deprivation therapy. Eur Urol 2002;42(1):12-17.
31. Pelletier G. Localization of androgen and estrogen receptors in rat and primate tissues. Histol Histopathol 2000;15(4):1261-1270.
32. Singer EA, Golijanin DJ, Messing EM. Androgen deprivation therapy for advanced prostate cancer: Why does it fail and can its effects be prolonged? Can J Urol 2008;15(6):4381-4387.
33. Wu CT, Altuwaijri S, Ricke WA, Huang SP, Yeh S, Zhang C, Niu Y, Tsai MY, Chang C. Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc Natl Acad Sci USA 2007;104(31):12679-12684. (Pubitemid 47255214)
34. Rodriguez-Acebes S, de la Cueva P, Fernandez-Hernando C, Ferruelo AJ, Lasuncion MA, Rawson RB, Martinez-Botas J, Gomez-Coronado D. Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line. Biochem J 2009; 420(2):305-315.
35. Bae SH, Paik YK. Cholesterol biosynthesis from lanosterol: Development of a novel assay method and characterization of rat liver microsomal lanosterol delta 24-reductase. Biochem J 1997; 326:609-616. (Pubitemid 27417244)
36. Yuan X, Balk SP. Mechanisms mediating androgen receptor reactivation after castration. Urol Oncol 2009;27(1):36-41.
37. Leon CG, Locke JA, Adomat HH, Etinger SL, Twiddy AL, Neumann RD, Nelson CC, Guns ES, Wasan KM. Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model. Prostate 2009 [Epub ahead of print].
38. Ifere GO, Barr E, Equan A, Gordon K, Singh UP, Chaudhary J, Igietseme JU, Ananaba GA. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines. Cancer Detect Prev 2009;32(4):319-328.
39. Biancolella M, Valentini A, Minella D, Vecchione L, D'Amico F, Chillemi G, Gravina P, Bueno S, Prosperini G, Desideri A, Federici G, Bernardini S, Novelli G. Effects of dutasteride on the expression of genes related to androgen metabolism and related pathway in human prostate cancer cell lines. Invest New Drugs 2007;25(5):491-497.